X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse ASTRAZENECA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ASTRAZENECA PHARMA    Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
ASTRAZENECA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,285354-   
Low Rs634255-   
Sales per share (Unadj.) Rs189.6105.2-  
Earnings per share (Unadj.) Rs-0.2-26.5-  
Cash flow per share (Unadj.) Rs3.8-22.0-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs68.682.6-  
Shares outstanding (eoy) m25.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.12.9 174.9%   
Avg P/E ratio x-4,712.7-11.5 41,041.7%  
P/CF ratio (eoy) x249.6-13.9 -1,801.3%  
Price / Book Value ratio x14.03.7 379.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m23,98851,396 46.7%   
No. of employees `0001.64.3 36.3%   
Total wages/salary Rs m1,6053,226 49.7%   
Avg. sales/employee Rs Th3,040.24,137.7 73.5%   
Avg. wages/employee Rs Th1,029.2751.4 137.0%   
Avg. net profit/employee Rs Th-3.3-1,042.6 0.3%   
INCOME DATA
Net Sales Rs m4,74017,763 26.7%  
Other income Rs m92124 74.0%   
Total revenues Rs m4,83217,888 27.0%   
Gross profit Rs m-130-3,078 4.2%  
Depreciation Rs m101767 13.2%   
Interest Rs m0481 0.0%   
Profit before tax Rs m-139-4,202 3.3%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1390-   
Tax Rs m5263 1.9%   
Profit after tax Rs m-5-4,476 0.1%  
Gross profit margin %-2.7-17.3 15.8%  
Effective tax rate %-3.7-6.2 58.6%   
Net profit margin %-0.1-25.2 0.4%  
BALANCE SHEET DATA
Current assets Rs m2,72613,010 21.0%   
Current liabilities Rs m2,4357,320 33.3%   
Net working cap to sales %6.132.0 19.2%  
Current ratio x1.11.8 63.0%  
Inventory Days Days74111 66.5%  
Debtors Days Days41124 32.9%  
Net fixed assets Rs m1,0357,584 13.7%   
Share capital Rs m5082 60.6%   
"Free" reserves Rs m9420-   
Net worth Rs m1,71613,942 12.3%   
Long term debt Rs m04,900 0.0%   
Total assets Rs m4,15626,338 15.8%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.7 169.1%   
Return on assets %-0.1-15.2 0.8%  
Return on equity %-0.3-32.1 0.9%  
Return on capital %0-19.8 0.0%  
Exports to sales %5.70-   
Imports to sales %6.50-   
Net fx Rs m-960-   
CASH FLOW
From Operations Rs m-81,516 -0.5%  
From Investments Rs m-146-466 31.3%  
From Financial Activity Rs m8624,447 19.4%  
Net Cashflow Rs m7095,497 12.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.88 Rs / ZAR

Compare ASTRAZENECA PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: PLETHICO PHARMA  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Indian Indices Continue Downtrend; Realty Stocks Top Losers(01:30 pm)

After opening the day lower, share markets in India have continued the downtrend and are currently trading below the dotted line. Sectoral indices are trading on a negative note with stocks.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Rule-Based Investing Can Make A Lot of Money(The 5 Minute Wrapup)

Sep 16, 2017

We take a glimpse of Equitymaster's results from rule based investing.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Gold Imports Surge: Are People Hedging the Risk of Another Demonetisation?(Vivek Kaul's Diary)

Sep 19, 2017

Imports of the yellow metal have surged big time this year.

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

A Little-Known Japanese Secret for Compounding Wealth

Sep 22, 2017

What Warren Buffett and Benjamin Graham have in common with a little known Japanese secret.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Sep 25, 2017 03:18 PM

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS